Parabilis Medicines, a clinical-stage biopharmaceutical company, announced its participation in three key investor conferences in November 2026: Guggenheim Healthcare Innovation Conference, Jefferies Global Healthcare Conference, and Evercore ISI Annual Healthcare Conference. CEO Mathai Mammen and the management team will present and hold fireside chats, with live webcasts available on the company’s website. This engagement highlights Parabilis' ongoing efforts to advance its novel medicines, including its lead candidate zolucatetide, targeting diseases driven by the Wnt/β-catenin pathway. Investors and stakeholders can expect updates on clinical progress and strategic direction during these events.
Parabilis Medicines is the subject, here is Pluang's health sector snapshot as of Nov 03, 2026 19:02 WIB: Of 150 priced US health stocks, 74 rose and 69 fell. Koninklijke Philips NV (PHG) rose 5.94% to USD 29.23 with a typical hold time of 86 days. Inovio Pharmaceuticals Inc (INO) fell 5.56% to USD 1.78, with 51% sell orders and a 42-day hold time. Nuwellis Inc (NUWE) dropped 5.41% to USD 4.90, with 45% sell orders and a 30-day hold time.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
